Document is current
Any future updates will be listed below
-
Authors
Mancini, Manuela
Monaldi, Cecilia
De Santis, Sara
Papayannidis, Cristina
Rondoni, Michela
Sartor, Chiara
Bruno, Samantha
Pagano, Livio
Criscuolo, Marianna
Zanotti, Roberta
Bonifacio, Massimiliano
Tosi, Patrizia
Arock, Michel
Valent, Peter
Cavo, Michele
Soverini, Simona
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (23001, 23001, 23001, 23001)
Austrian Science Fund (F4704-B20)
- License Information
-
More Information
Article History
Received: 15 December 2022
Accepted: 22 February 2023
First Online: 10 March 2023
Declarations
:
: Sample collection was approved by the Institutional Review Boards of the S. Orsola-Malpighi Hospital (protocol 112/2014/U/Tess) and of the other institutions participating in this study.
: Not applicable.
: CP received honoraria for consultancy from Novartis and Blueprint; RZ received honoraria for consultancy from Novartis and Blueprint; PV received honoraria for consultancy from Novartis, Celgene/BMS, Incyte, Blueprint, Pfizer. MA received honoraria for consultancy from AB Science, Blueprint, Novartis. The remaining authors declare no conflicts of interests.
